Institutional Ownership Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). We have compiled data on the 83 institutions that hold shares in the stock, with a total of 150 Million shares, which have been reported (via 13F filing form) to have a value of $89.9 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Matrix Capital Management Company, LP
Waltham, MA |
Nov 14, 2024 Q3 2024 |
37,681,515
shares
|
$22.6 Million
1.71% of portfolio
|
Q3 2024
Reduced 3.32%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
27,404,070
shares
|
$16.4 Million
1.13% of portfolio
|
Q1 2024
New holding
|
|
|
Nea Management Company, LLC
Timonium, MD |
Nov 14, 2024 Q3 2024 |
17,079,778
shares
|
$10.2 Million
1.24% of portfolio
|
Q2 2023
Reduced -0.0%
|
|
|
Baillie Gifford & CO
|
Nov 05, 2024 Q3 2024 |
16,775,860
shares
|
$10.1 Million
0.01% of portfolio
|
Q3 2024
Added 10.74%
|
|
|
Long Focus Capital Management, LLC
San Juan, PR |
Nov 13, 2024 Q3 2024 |
13,299,890
shares
|
$7.98 Million
0.46% of portfolio
|
Q3 2024
Added 7.72%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
10,000,787
shares
|
$6 Million
0.56% of portfolio
|
Q3 2024
Reduced 4.94%
|
|
|
Mpm Asset Management LLC
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
5,555,461
shares
|
$3.33 Million
3.63% of portfolio
|
Q4 2023
Reduced 11.64%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
5,095,912
shares
|
$3.06 Million
0.76% of portfolio
|
Q2 2023
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
4,653,325
shares
|
$2.79 Million
0.0% of portfolio
|
Q2 2024
Reduced 0.31%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,425,468
shares
|
$1.46 Million
0.08% of portfolio
|
Q4 2023
Reduced 13.0%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,699,025
shares
|
$1.02 Million
0.0% of portfolio
|
Q3 2024
Added 285.41%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
1,656,575
shares
|
$993,945
0.0% of portfolio
|
Q3 2024
Reduced 7.26%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
1,045,533
shares
|
$627,319
0.0% of portfolio
|
Q3 2024
Added 0.8%
|
|
|
Redmile Group, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
715,607
shares
|
$429,364
0.04% of portfolio
|
Q2 2023
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
715,350
shares
|
$429,210
0.0% of portfolio
|
Q3 2024
Reduced 8.24%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
522,608
shares
|
$313,564
0.0% of portfolio
|
Q3 2024
Added 260.72%
|
|
|
Rathbones Group PLC
Liverpool, X0 |
Nov 13, 2024 Q3 2024 |
432,818
shares
|
$259,690
0.0% of portfolio
|
Q4 2021
Reduced 0.02%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
396,792
shares
|
$238,075
0.0% of portfolio
|
Q3 2024
Added 1.51%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2024 Q3 2024 |
341,064
shares
|
$204,638
0.08% of portfolio
|
Q1 2024
Reduced 2.85%
|
|
|
Key Client Fiduciary Advisors, LLC
|
Oct 18, 2024 Q3 2024 |
255,359
shares
|
$153,215
0.12% of portfolio
|
Q3 2024
Reduced 3.27%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
193,757
shares
|
$116,254
0.0% of portfolio
|
Q2 2024
Reduced 33.12%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
189,472
shares
|
$113,683
0.0% of portfolio
|
Q3 2024
Reduced 21.75%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
174,157
shares
|
$104,494
0.0% of portfolio
|
Q3 2024
Added 130.44%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
139,801
shares
|
$83,880
0.0% of portfolio
|
Q3 2024
Added 18.57%
|
|
|
Virtu Financial LLC
New York, NY |
Nov 20, 2024 Q3 2024 |
101,008
shares
|
$60,604
0.01% of portfolio
|
Q3 2024
Added 27.47%
|